Table 2.
Type of CARV and mortality by CARV type according to prospective vs. retrospective nature of cohort and CARV upper or lower respiratory tract disease.
| EvRh | RSV | Influ | HPiV | hMPV | AdV | HCoV | HBoV | |
|---|---|---|---|---|---|---|---|---|
| Prospective CARV episodes, n | 126 | 60 | 58 | 48 | 27 | 4 | 15 | 15 |
| 90-day overall mortality, n (%)a | 5 (4) | 3 (5) | 1 (2) | 1 (2) | 0 | 0 | 0 | 0 |
| CARV URTD, n (%)a | 91 (72) | 42 (70) | 40 (69) | 30 (65) | 16 (59) | 3 (75) | 12 (80) | 12 (80) |
| 90-day overall mortality, n (%)a | 3 (3) | 1 (2) | 0 | 1 (3) | 0 | 0 | 0 | 0 |
| CARV LRTD, n (%)a | 35 (28) | 18 (30) | 18 (31) | 17 (35) | 11 (41) | 1 (25) | 3 (20) | 3 (20) |
| 90-day overall mortality, na | 2 (6) | 2 (11) | 1 (6) | 0 | 0 | 0 | 0 | |
| Retrospective CARV episodes, n | 24 | 43 | 31 | 15 | 11 | 3 | 0 | 1 |
| 90-day overall mortality, n (%)a | 6 (25) | 11 (26) | 4 (13) | 4 (27) | 4 (36) | 1 (25) | - | 0 |
| CARV URTD, n (%)a | 11 (46) | 14 (32) | 14 (45) | 7 (46) | 4 (36) | 0 | - | 0 |
| 90-day overall mortality, n (%)a | 0 | 0 | 0 | 0 | 0 | - | - | - |
| CARV LRTD, n (%)a | 13 (54) | 29 (68) | 17 (55) | 8 (54) | 7 (64) | 2 (75) | - | 1 (100) |
| 90-day overall mortality, n (%)a | 6 (46) | 11 (38) | 4 (23) | 4 (50) | 4 (57) | 1 (50) | - | 0 |
Abbreviations: CARV, community-acquired respiratory virus; EvRh, Enterovirus/rhinovirus; ADV, adenovirus; RSV, respiratory syncytial virus; HPiV, human parainfluenza virus; hMPV, human metapneumovirus; HCoV, human coronavirus; Influ, human influenza virus; AdV, adenovirus; IFD, invasive pulmonary fungal disease; URTD, upper respiratory tract disease; LRTD, lower respiratory tract disease.
a
The sum total of the episodes does not match the overall number of episodes (n = 404) since multiple CARVs were detected in the same respiratory sample in 66 (16%) CARV episodes.